Skip NavigationSkip to Content

Kinetically Controlled Polyelectrolyte Complex Assembly of microRNA-Peptide Nanoparticles toward Treating Mesothelioma

  1. Author:
    Anderson,Caleb
    Singh, Anand
    Stephens,Tyler
    Hoang, Chuong D
    Schneider,Joel [ORCID]
  2. Author Address

    Chemical Biology Laboratory, National Cancer Institute, National Institutes of Health, Frederick, MD, 21701, USA., Thoracic Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA., Vaccine Research Center Electron Microscopy Unit, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, 20701, USA.,
    1. Year: 2024
    2. Date: Mar 26
    3. Epub Date: 2024 03 26
  1. Journal: Advanced Materials (Deerfield Beach, Fla.)
    1. Pages: e2314367
  2. Type of Article: Article
  3. Article Number: e2314367
  1. Abstract:

    Broad size distributions and poor long-term colloidal stability of microRNA-carrying nanoparticles, especially those formed by polyelectrolyte complexation, represent major hurdles in realizing their clinical translation. Herein, peptide design is used alongside optimized flash nanocomplexation (FNC) to produce uniform peptide-based miRNA particles of exceptional stability that display anticancer activity against mesothelioma in vitro and in vivo. Modulating the content and display of lysine-based charge from small intrinsically disordered peptides used to complex miRNA proved essential in achieving stable colloids. FNC facilitates kinetic isolation of the mechanistic steps involved in particle formation to allow the preparation of particles of discrete size in a highly reproducible, scalable, and continuous manner, facilitating pre-clinical studies. To our knowledge, this work represents the first example of employing FNC to prepare polyelectrolyte complexes of miRNA and peptide. Encapsulation of these particles into an injectable hydrogel matrix allows for their localized in vivo delivery by syringe. A one-time injection of a gel containing particles composed of miRNA-215-5p and the peptide PKM1 limited tumor progression in a xenograft model of mesothelioma. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

    See More

External Sources

  1. DOI: 10.1002/adma.202314367
  2. PMID: 38532642

Library Notes

  1. Fiscal Year: FY2023-2024
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel